| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |